Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

721. The effects of emotion-oriented approaches in the care for persons suffering from dementia: a review of the literature

The effects of emotion-oriented approaches in the care for persons suffering from dementia: a review of the literature The effects of emotion-oriented approaches in the care for persons suffering from dementia: a review of the literature The effects of emotion-oriented approaches in the care for persons suffering from dementia: a review of the literature Finnema E, Droes R M, Ribbe M, Van Tilburg W Authors' objectives To assess the effectiveness of emotion-orientated approaches in the care (...) of people with dementia. Searching MEDLINE, PsycLIT, EMBASE, Sociofile, and Current Contents were searched from 1990 to 1999 using the terms 'dementia' and 'Alzheimer's disease' linked separately to the following terms: 'emotion-orientated', 'validation (therapy)', 'sensory integration/sensory stimulation/snoezelen/multi-sensory environment/multi-sensory enhancement', 'stimulated presence therapy' and ' reminiscence (therapy)/life review'. References from identified studies were examined, and additional

2000 DARE.

722. Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trials

Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trials Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trials Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trials Davidson M, Weiser M, Soares K Authors' objectives (...) To assess the quality and results of trials of atypical antipsychotics in elderly patients with behavioural and psychological symptoms of dementia. Searching The Cochrane Controlled Trials Register (Issue 2, 1999) and MEDLINE (to June 1999) were searched using the following keywords in combination with 'dementia': 'risperidone', 'olanzapine', ziprasidone', 'quetiapine', 'sertindole' and 'clozapine'. Reference lists of RCTs were also checked and pharmaceutical companies that produced these drugs were

2000 DARE.

723. Specialized continuing care models for persons with dementia: a systematic review of the research literature

Specialized continuing care models for persons with dementia: a systematic review of the research literature Specialized continuing care models for persons with dementia: a systematic review of the research literature Specialized continuing care models for persons with dementia: a systematic review of the research literature Roberts J, Browne G, Gafni A, Varieur M, Loney P, de Ruijter M Authors' objectives To identify and assess the effectiveness of services or models of care for persons (...) with dementia living in their homes, in specialised care units, or in assisted-living centres or congregate homes. Searching MEDLINE, CINAHL and Health were searched from 1986 to 1996. The search terms included 'long term care', 'dementia', 'Alzheimer's Disease', 'caregivers', and various terms relating to residence and service provision, e.g. 'special care unit' and 'respite', respectively. The reference lists of retrieved articles, and regional Canadian research reports known to the author, were also

2000 DARE.

724. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia

Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia Gifford D R, Holloway R G, Vickrey B G Authors' objectives To review systematically primary research studies on clinical prediction rules for neuroimaging in the evaluation of dementia, and to assess the sensitivity (...) , specificity and diagnostic performance of the rules. Searching MEDLINE was searched from January 1, 1983, to December 31, 1998. The keywords used were described in the paper. In addition, the authors identified articles from an in-depth review of bibliographies of textbooks, review articles and guidelines on dementia. Study selection Study designs of evaluations included in the review Diagnostic accuracy studies were eligible for inclusion. Specific interventions included in the review Studies in dementia

2000 DARE.

725. Is music therapy an effective intervention for dementia: a meta-analytic review of literature

Is music therapy an effective intervention for dementia: a meta-analytic review of literature Is music therapy an effective intervention for dementia: a meta-analytic review of literature Is music therapy an effective intervention for dementia: a meta-analytic review of literature Koger S M, Chapin K, Brotons M Authors' objectives To update a previous review and to quantify the relationship of music or music therapy as an effective intervention for dementia. In addition, to investigate (...) the extent to which methodological variables influenced the effectiveness of treatment. Searching The authors used the literature that had been identified for a qualitative review (see Other Publications of Related Interest no.1). In addition, MEDLINE (1975 to present)and PsycLIT (1974 to present) were searched using 'music and dementia' and 'music and Alzheimer's' as the keywords. Study selection Study designs of evaluations included in the review The majority of the studies selected were within-patient

1999 DARE.

726. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review

The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review Opie J, Rosewarne R, O'Connor D W Authors' objectives To provide a systematic review of research findings published between 1989 and 1998 concerning non-pharmacological (...) strategies to alleviate behavioural disturbances in elderly persons with dementia. Searching Manual searches of selected journals (Age and Aging, Alzheimer's Disease and Associated Disorders, American Journal of Alzheimer's Care and Related Disorders, Australian and New Zealand Journal of Psychiatry, Australian Journal on Aging, British Journal of Psychiatry, Dementia, Geriatrics, Geriatric Nursing, Gerontological Nursing, International Psychogeriatrics, Journal of Gerontology, Journal of American

1999 DARE.

727. A review of the use of propentofylline in the treatment of dementia

A review of the use of propentofylline in the treatment of dementia A review of the use of propentofylline in the treatment of dementia A review of the use of propentofylline in the treatment of dementia Chilcott J, Perrett K, Golightly P, Sykes J, Whittingham M Authors' objectives To assess the effectiveness of propentofylline in the treatment of dementia. Searching The authors searched MEDLINE, EMBASE, HealthSTAR, the Cochrane Controlled Trials Register and the NHS Centre for Reviews (...) Propentofylline for the intervention group and placebo for the control group. Participants included in the review Patients with dementia (including patients with mild to moderate Alzheimer's disease of vascular dementia). Outcomes assessed in the review Global function, cognitive function and activities of daily living measured using primary and secondary outcome measures. The primary outcome measures were: the Gottfries-Brane-Steen (GBS) scale, the Clinical Global Impression (CGI), and the Syndrome Short

1999 DARE.

728. The use of CT scanning in dementia: a systematic review

The use of CT scanning in dementia: a systematic review The use of CT scanning in dementia: a systematic review The use of CT scanning in dementia: a systematic review Foster G R, Scott D A, Payne S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions (...) drawn. Health technology The use of CT scanning in dementia. Type of intervention Screening and treatment. Economic study type Cost-utility analysis. Study population Male and female patients above and below 65 years of age with newly-diagnosed dementia without a theoretically treatable condition. Setting Hospital. The study was carried out in Scotland, UK. Dates to which data relate The effectiveness data were derived from studies previously published between 1972 and 1996. The dates during which

1999 NHS Economic Evaluation Database.

729. Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials

Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials Ernst E, Pittler M H Authors' objectives To systematically review the clinical evidence of Ginkgo biloba preparations as a symptomatic treatment for dementia. Searching MEDLINE, EMBASE, BIOSIS Previews, and the Cochrane (...) Library were searched from inception to March 1998. The search terms used were 'ginkgo', 'gingko', 'Ginkgo biloba', 'dementia' and 'Alzheimer'. Additional references were found by examining the bibliographies of the identified studies, and by scanning the authors' files and books related to the topic. The manufacturers of Ginkgo biloba preparations were asked to contribute published and unpublished material. Studies reported in any language were considered. Study selection Study designs of evaluations

1999 DARE.

730. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. (Abstract)

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Systolic hypertension increases the risk of dementia in elderly people. The vascular dementia project, set up in the framework of the double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, investigated whether antihypertensive drug treatment could reduce the incidence of dementia.Eligible patients had no dementia, were at least 60 years old, and had (...) a blood pressure when seated of 160-219 mm Hg systolic and below 95 mm Hg diastolic. Active treatment consisted of nitrendipine (10-40 mg/day) with the possible addition of enalapril (5-20 mg/day), hydrochlorothiazide (12.5-25 mg/day), or both drugs, titrated or combined to reduce the systolic blood pressure by at least 20 mm Hg to reach a value below 150 mm Hg. Cognitive function was assessed by the mini mental state examination (MMSE). If the MMSE score was 23 or less, diagnostic tests for dementia

1998 Lancet Controlled trial quality: predicted high

731. Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT)

Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT) Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT) Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT) Stein K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Stein K (...) . Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT) Southampton: Wessex Institute for Health Research and Development (WIHRD) 1998 Authors' objectives To summarise the evidence for the cost effectiveness of rivastigmine, an acetylcholinesterase inhibitor taken twice daily, to be made available to people with mild to moderate SDAT (MMSE 10-26). Authors' conclusions The evidence, from a relatively large series of phase III trials, appears to be of moderate methodological

1998 Health Technology Assessment (HTA) Database.

732. The primary care management of dementia

The primary care management of dementia The primary care management of dementia The primary care management of dementia North of England Evidence Based Guideline Development Project Authors' objectives To provide recommendations, to aid primary health professionals in their management of people with all forms of dementia and their carers. Searching The search strategy was carried out using the electronic databases MEDLINE (covering the period 1966 to 1996), EMBASE (via BIDS)(1980 to 1996 (...) to them that did not appear in the search results. No attempt was made to access the grey literature (unpublished reports and abstracts), nor were letters identified in response to original articles. An additional search was made for anti-dementia drugs. The search strategy attempted to locate systematic reviews and meta analyses, randomised trials, quality-of-life studies and economic studies using a combination of subject heading and free text searches. In addition, contact was made with subject

1998 DARE.

733. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia Estrogen therapy in postmenopausal women: effects on cognitive function and dementia Estrogen therapy in postmenopausal women: effects on cognitive function and dementia Yaffe K, Sawaya G, Lieberburg I, Grady D Authors' objectives To determine whether postmenopausal oestrogen replacement therapy improves cognition, prevents development of dementia, and improves the severity of dementia. Searching MEDLINE (...) : the effect of oestrogen on cognitive function in nondemented women; the effect of oestrogen on the risk of developing Alzheimer's disease (AD) or other dementia; and the effect of oestrogen treatment in women with AD. Multiple outcome measures were used to estimate the effect of oestrogen on cognitive function in nondemented women and in women with AD. How were decisions on the relevance of primary studies made? The authors do not state how the papers were selected for the review, or how many

1998 DARE.

734. Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview

Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview Forbes D A Authors' objectives To assess and summarise research evidence on the effectiveness of strategies within the scope of nursing (...) in managing the behavioural symptomatology associated with dementia of the Alzheimer type in elderly individuals. Searching MEDLINE, CINAHL, PsycINFO, Sociofile, Ageline, HealthSTAR, Dissertation Abstracts, Government Documents (First Search), and CAN Research Index were searched from January 1985 to April 1997. The search terms were provided. Key journals such as The Gerontologist and the Journal of the American Geriatrics Society were manually searched and several key informants were contacted

1998 DARE.

735. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia Efficacy and safety of neuroleptics in behavioral disorders associated with dementia Efficacy and safety of neuroleptics in behavioral disorders associated with dementia Lanctot K L, Best T S, Mittmann N, Liu B A, Oh P I, Einarson T R, Naranjo C A Authors' objectives To compare the efficacy and safety of neuroleptics versus placebo in the treatment of behavioural disorders in patients with dementia. Searching (...) MEDLINE was searched from 1966 to 1995 for publications in the English language. The keywords were 'antipsychotic agents', 'phenothiazines', or 'butyrophenones'; and 'dementia'; and 'behavior therapy' or 'behavior'. Additional material was identified by the manual cross-referencing of recent reviews and the retrieved papers, and by consulting experts. Study selection Study designs of evaluations included in the review The included studies were randomised controlled trials (RCTs) of at least one

1998 DARE.

736. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. (Abstract)

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. EGb 761 is a particular extract of Ginkgo biloba used in Europe to alleviate symptoms associated with numerous cognitive disorders. Its use in dementias is based on positive results from only a few controlled clinical trials, most of which did not include standard assessments of cognition and behavior.To assess the efficacy and safety of EGb in Alzheimer disease (...) and multi-infarct dementia.A 52-week, randomized double-blind, placebo-controlled, parallel-group, multicenter study.Mildly to severely demented outpatients with Alzheimer disease or multi-infarct dementia, without other significant medical conditions.Patients assigned randomly to treatment with EGb (120 mg/d) or placebo. Safety, compliance, and drug dispensation were monitored every 3 months with complete outcome evaluation at 12, 26, and 52 weeks.Alzheimer's Disease Assessment Scale-Cognitive subscale

1997 JAMA Controlled trial quality: predicted high

737. Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT)

Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT) Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT) Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT) Stein K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Stein K (...) . Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT) Southampton: Wessex Institute for Health Research and Development (WIHRD) 1997 Authors' objectives Donepezil is a new drug treatment, recently licensed in the UK, for use in mild to moderate dementia due to senile dementia of the Alzheimer type (SDAT). The author assesses whether it should be made available to all patients with mild to moderate SDAT. Authors' conclusions The effectiveness of donepezil in routine

1997 Health Technology Assessment (HTA) Database.

738. Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test

Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test Jorm A F Authors' objectives To clarify the relative performance of an informant questionnaire with a brief cognitive (...) test in screening for dementia, or dementia plus delirium. Searching MEDLINE and PsycLIT were searched using the keywords 'dementia' or 'cognitive' and 'informant' or 'proxy'. The review by Jorm 1996 (see Other Publications of Related Interest) was searched for citations, as were the reference lists of all located studies, and researchers in the area (including the authors of all known informant questionnaires) were contacted. Study selection Study designs of evaluations included in the review

1997 DARE.

739. Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients

Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients Mintzer J E, Colenda C, Waid L R, Lewis L, Meeks A, Stuckey M, Bachman D L, Saladin M, Sampson R R Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A continuum of care using brief and partial hospitalizationfor agitated dementia patients. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients with different ethnic backgrounds diagnosed with both

1997 NHS Economic Evaluation Database.

740. Cost-utility analysis of group living in dementia care

Cost-utility analysis of group living in dementia care Cost-utility analysis of group living in dementia care Cost-utility analysis of group living in dementia care Wimo A, Mattson B, Krakau I, Eriksson T, Nelvig A, Karlsson G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Care settings for dementia patients. Type of intervention Secondary prevention Economic study type Cost-utility analysis Study population Elderly people with dementia. The mean age of patients was 79 with a ratio of approximately 2 Setting The three different residence regimes of group living, home living and institutional living were compared in Sundsvall, an industrial city in central Sweden. Dates to which data relate Patients were admitted

1995 NHS Economic Evaluation Database.